Before, Andreas Birkenfeld as divisional head held the Professorship for Metabolic and Vascular Medicine at the Technical University Dresden and headed a working group at the Institute of Pancreatic Islet Research, Paul-Langerhans-Institute Dresden of the DZD partner Helmholtz Zentrum München. His research focuses on novel regulators of energy, glucose, and lipid homeostasis and their impact on insulin resistance, type 2 diabetes, obesity and aging ultimately aiming at the development of more effective therapeutic strategies.
As an important partner in the German Center of Diabetes Research (DZD), the IDM will expand on its successful research foci in the areas prevention, therapy and mechanisms in close connection with the further development and research of the patient cohorts and novel therapies for type 2 diabetes in Tübingen.